3-Methylthiofentanyl: Difference between revisions

Browse history interactively ← Previous editContent deleted Content addedVisual WikitextInline

Revision as of 01:04, 1 September 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or bugs)← Previous edit		Latest revision as of 02:57, 11 March 2024 edit undoChonchiGamer (talk \| contribs)10 editsm Fixed typo #article-section-source-editorTags: Mobile edit Mobile app edit iOS app edit
(27 intermediate revisions by 22 users not shown)
Line 1:		Line 1:
			{{Short description\|Opioid analgesic}}
	{{Drugbox		{{Drugbox
			\| Verifiedfields = changed
	\| verifiedrevid = ~~443350651~~		\| verifiedrevid = 477219808
	\| IUPAC_name = (''RS'')-''N''-{3-~~methyl~~-1-piperidin-4-yl}-''N''-phenylpropanamide		\| IUPAC_name = (''RS'')-''N''-{3-Methyl-1-piperidin-4-yl}-''N''-phenylpropanamide
	\| image = 3-Methylthiofentanyl.svg		\| image = 3-Methylthiofentanyl.svg

Line 10:		Line 12:
	\| pregnancy_category =		\| pregnancy_category =
	\| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->		\| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
			\| legal_BR = F1
	\| legal_CA = Schedule I		\| legal_CA = Schedule I
	\| legal_UK = Class A		\| legal_UK = Class A
	\| legal_US = Schedule I		\| legal_US = Schedule I
	\| ~~legal_status~~ =		\| legal_DE = Anlage I
	\| routes_of_administration =		\| routes_of_administration =

	<!--Pharmacokinetic data-->		<!--Pharmacokinetic data-->
Line 21:		Line 24:
	\| metabolism =		\| metabolism =
	\| elimination_half-life =		\| elimination_half-life =
	\| excretion =		\| excretion =

	<!--Identifiers-->		<!--Identifiers-->
			\| CAS_number_Ref = {{cascite\|changed\|??}}
	\| CAS_number = 86052-04-2		\| CAS_number = 86052-04-2
	\| ATC_prefix =		\| ATC_prefix =
	\| ATC_suffix =		\| ATC_suffix =
	\| PubChem = 62296		\| PubChem = 62296
			\| KEGG = C22790
	\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}		\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}
	\| DrugBank = DB01439		\| DrugBank = DB01439
Line 34:		Line 39:
	\| ChEBI_Ref = {{ebicite\|correct\|EBI}}		\| ChEBI_Ref = {{ebicite\|correct\|EBI}}
	\| ChEBI = 53763		\| ChEBI = 53763
			\| UNII_Ref = {{fdacite\|changed\|FDA}}
			\| UNII = C9C204973M

	<!--Chemical data-->		<!--Chemical data-->
	\| C=21 \| H=28 \| N=2 \| O=1 \| S=1		\| C=21 \| H=28 \| N=2 \| O=1 \| S=1
	\| molecular_weight = 356.526 g/mol
	\| smiles = O=C(N(c1ccccc1)C2CCN(CC2C)CCc3sccc3)CC		\| smiles = O=C(N(c1ccccc1)C2CCN(CC2C)CCc3sccc3)CC
	\| InChI = 1/C21H28N2OS/c1-3-21(24)23(18-8-5-4-6-9-18)20-12-14-22(16-17(20)2)13-11-19-10-7-15-25-19/h4-10,15,17,20H,3,11-14,16H2,1-2H3
	\| InChIKey = SRARDYUHGVMEQI-UHFFFAOYAM
	\| StdInChI_Ref = {{stdinchicite\|correct\|chemspider}}		\| StdInChI_Ref = {{stdinchicite\|correct\|chemspider}}
	\| StdInChI = 1S/C21H28N2OS/c1-3-21(24)23(18-8-5-4-6-9-18)20-12-14-22(16-17(20)2)13-11-19-10-7-15-25-19/h4-10,15,17,20H,3,11-14,16H2,1-2H3		\| StdInChI = 1S/C21H28N2OS/c1-3-21(24)23(18-8-5-4-6-9-18)20-12-14-22(16-17(20)2)13-11-19-10-7-15-25-19/h4-10,15,17,20H,3,11-14,16H2,1-2H3
Line 48:		Line 52:
	}}		}}

	'''3-~~Methyl-thiofentanyl~~''' is an ] ] ~~that is an~~ ] of ].		'''3-Methylthiofentanyl''' is an ] ] and ] of ].

	3-~~Methyl-thiofentanyl~~ was sold briefly on the black market in the early 1980s, before the introduction of the ] which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared. <ref> Henderson GL. Designer Drugs: Past History and Future Prospects. Journal of Forensic Sciences ~~1988;~~ 33(2~~):569-575~~. </ref>		3-Methylthiofentanyl was sold briefly on the black market in the early 1980s, before the introduction of the ] which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared.<ref>{{cite journal \| last1 = Henderson \| first1 = GL \| year = 1988 \| title = Designer Drugs: Past History and Future Prospects \| journal = Journal of Forensic Sciences \| volume = 33 \| issue = 2\| pages = 569–575 \| doi = 10.1520/JFS11976J \| pmid = 3286815 }}</ref>

	3-~~Methyl-thiofentanyl~~ has similar effects to fentanyl. Side effects of fentanyl ~~analogues~~ are similar to those of fentanyl itself, which include ], ] and potentially serious ] which can be life-threatening.		3-Methylthiofentanyl has similar effects to fentanyl. Side effects of ] analogs are similar to those of fentanyl itself, which include ], ] and potentially serious ], which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.<ref>{{cite journal \| url=http://www.ijdp.org/article/S0955-3959%2815%2900097-3/abstract \| title=Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. \| vauthors = Mounteney J, Giraudon I, Denissov G, Griffiths P \| journal=The International Journal of Drug Policy \| date=July 2015 \| volume=26 \| issue=7 \| pages=626–631 \| doi=10.1016/j.drugpo.2015.04.003 \| pmid=25976511\| url-access=subscription }}</ref>

			==See also==
			* ]
			* ]
			* ]
			* ]
			* ]
			* ]

	== References ==		== References ==
			{{Reflist}}
	<references />

			{{Opioidergics}}

	{{DEFAULTSORT:Methylthiofentanyl, 3-}}		{{DEFAULTSORT:Methylthiofentanyl, 3-}}
Line 63:		Line 77:
	]		]
	]		]
	]		]

	{{analgesic-stub}}

Latest revision as of 02:57, 11 March 2024

Opioid analgesic Pharmaceutical compound

3-Methylthiofentanyl
Clinical data

Other names	N--N-phenyl-propanamide; 3-methyl-thiofentanyl
Legal status
Legal status	BR: Class F1 (Prohibited narcotics) CA: Schedule I DE: Anlage I (Authorized scientific use only) UK: Class A US: Schedule I
Identifiers
IUPAC name (RS)-N-{3-Methyl-1-piperidin-4-yl}-N-phenylpropanamide
CAS Number	86052-04-2
PubChem CID	62296
DrugBank	DB01439
ChemSpider	56092
UNII	C9C204973M
KEGG	C22790
ChEBI	CHEBI:53763
CompTox Dashboard (EPA)	DTXSID60861311
Chemical and physical data
Formula	C₂₁H₂₈N₂OS
Molar mass	356.53 g·mol
3D model (JSmol)	Interactive image
SMILES O=C(N(c1ccccc1)C2CCN(CC2C)CCc3sccc3)CC
InChI InChI=1S/C21H28N2OS/c1-3-21(24)23(18-8-5-4-6-9-18)20-12-14-22(16-17(20)2)13-11-19-10-7-15-25-19/h4-10,15,17,20H,3,11-14,16H2,1-2H3 Key:SRARDYUHGVMEQI-UHFFFAOYSA-N
(what is this?) (verify)

3-Methylthiofentanyl is an opioid analgesic and analogue of fentanyl.

3-Methylthiofentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analogue Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared.

3-Methylthiofentanyl has similar effects to fentanyl. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.

References

Henderson, GL (1988). "Designer Drugs: Past History and Future Prospects". Journal of Forensic Sciences. 33 (2): 569–575. doi:10.1520/JFS11976J. PMID 3286815.
Mounteney J, Giraudon I, Denissov G, Griffiths P (July 2015). "Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe". The International Journal of Drug Policy. 26 (7): 626–631. doi:10.1016/j.drugpo.2015.04.003. PMID 25976511.